Boiron SA (BOIRF)
OTCMKTS · Delayed Price · Currency is USD
24.00
0.00 (0.00%)
At close: Aug 6, 2025

Boiron Company Description

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy.

It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain.

In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia.

The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail.

Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Boiron SA
Boiron logo
CountryFrance
Founded1932
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees2,771
CEOPascal Houdayer

Contact Details

Address:
2, avenue de l’Ouest Lyonnais
Messimy, 69510
France
Phone33 4 78 45 61 00
Websiteboiron.fr

Stock Details

Ticker SymbolBOIRF
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberFR0000061129
SIC Code2834

Key Executives

NamePosition
Thierry BoironGM and Director
Eric LambertSecretary General and Chief Financial and Administrative Officer
Patrice VarrautDirector of Operations
Juliette BaudryHuman Resources Director
Jean-Christophe BayssatDeputy GM, Chief Pharmacist and Director of Pharmaceutical Development
Fabrice ReyGroup Treasurer